NIM
RCUS icon

NEOS Investment Management’s Arcus Biosciences RCUS Stock Holding History

NEOS Investment Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,665
Closed -$874K – 639
2025
Q4 		$874K Buy
36,665
+6,372
+21% +$130K 0.01% 564
2025
Q3 		$412K Sell
30,293
-29,369
-49% -$305K ﹤0.01% 593
2025
Q2 		$486K Buy
59,662
+44,411
+291% +$379K 0.01% 549
2025
Q1 		$120K Sell
15,251
-6,982
-31% -$80.9K ﹤0.01% 595
2024
Q4 		$331K Sell
22,233
-14,705
-40% -$240K 0.01% 548
2024
Q3 		$565K Buy
36,938
+2,332
+7% +$36.8K 0.02% 474
2024
Q2 		$527K Buy
34,606
+23,129
+202% +$373K 0.02% 441
2024
Q1 		$217K Buy
11,477
+336
+3% +$5.81K 0.01% 540
2023
Q4 		$213K Buy
+11,141
New +$178K 0.02% 487

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return